(1998) Centers for Disease Control and Prevention: Develoꠀpment of new vaccines for tuberculosis. Recomꠀmendations of the Advisory Council for the Elimiꠀnation of Tuberculosis(ACET). ,

et al. T cell epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 1994,

(1995) Variation in protection by BCG: impliꠀ;cations of and for heterologous immunity,

from Mycobacterium bovis bacile Calmette- Gu？rin is associated with proꠀ tective T cells in leprosy A follow-up study of 45 household contacts. J Infect Dis 1993,

(1996) Auxotrophic vaccines for tuberculosis,

(1995) Proꠀtective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis,

(2000) ESAT-6 subunit vaccination against Mycobacterium tuberculosis,

(2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and east-6,

(1996) Immunogenicity and protective efficacy of a tuberꠀculosis DNA vaccine,

(2003) The Apa protein of Mycobacꠀterium tuberculosis stimulates gamma interferon- secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model,

(1994) Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins,

(1992) A major secretion product of Mycobacterium tuberꠀ,

(1997) Conꠀ;struction of a Mycobacterium-Escherichia coli shutꠀtle vector and use in the expression of foreign genes in Mycobacteria,

(1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines,

(2000) Recombinant bacillus Calmette Gu？rin(BCG) vacꠀcines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater proꠀ;tective immunity against tuberculosis than convenꠀtional BCG vaccines in a highly susceptible animal model,

(2000) Inhibition of multiplication of Mycobacꠀterium leprae in mouse foot pads by recombinant Bacillus Catmette-Guerin(BCG),

(2001) Protective responses against experimenꠀtal Mycobacterium leprae infection in mice induced by recombinant bacillus Calmette-Gu？rin over-proꠀducing three putative protective antigen candidates,

(2000) Correlates of protective immunity to Mycobacterium tuberculosis in humans,

(1992) T Lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection,

(1993) Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection,

(1998) Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis,

(1995) T cell cytokine responses in human infection with Mycobacterium tuberculosis,

(1999) Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting actiꠀvation of STAT1,

(2003) Virulence, imꠀmunogenicity, and protective efficacy of two recomꠀbinant Mycobacterium bovis bacillus Calmette- Gu？rin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis,

(2003) Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums,